Richard J. Zall

New York

King & Spalding LLP
1185 Avenue of the Americas
34th Floor
New York, NY 10036

Tel: +1 212 556 2150


Rick Zall is a partner and chair of King & Spalding’s healthcare transactional and regulatory practice.

He represents clients on both transactional and regulatory healthcare matters, including advising healthcare operating companies, private equity investors and lenders on M&A, joint ventures, financings and complex commercial transactions.

He advises on state and federal healthcare regulatory compliance matters, including navigating fraud and abuse and corporate practice of medicine prohibitions, Medicare and Medicaid payment rules. Rick also counsels clients in the emerging digital health and health information technology sectors on compliance with data privacy and security laws, telemedicine licensure regulations and health benefit management.

With deep experience in the healthcare industry, Rick is known for practical and effective solutions to successfully structure, negotiate and close deals for his clients.

Rick advises clients on regulatory compliance matters including fraud and abuse, corporate practice of medicine, structuring physician incentive arrangements, digital health/telemedicine, HIPAA, Medicare/Medicaid reimbursement and value-based payments.

Prior to joining King & Spalding, Rick was a partner and the chairman of the healthcare practice for an Am Law 100 firm.

  • Represented Accuity Delivery Systems in its sale to an affiliate of private equity firm, Frazier Healthcare Partners.
  • Represented Apnicure, a healthcare technology and medical device company, in connection with regulatory compliance state telemedicine laws and corporate structuring.
  • Represented Ares Management LLC, as special healthcare counsel in its acquisitions of both OB Hospitalist Group and Unified Physician Management.
  • Represented Athenahealth in connection with regulatory compliance matters
  • Represented The Brooklyn Hospital Center in the establishment of ModernMD, an urgent care joint venture with Blue Wolf Capital.
  • Represented Cambia Health in the establishment of a joint venture platform for Cambia (Regence Blue Cross) and Blue Cross/Blue Shield of North Carolina.
  • Represented Cincinnati Eye Institute (CEI) in the launch of CEI Vision Partners, a new management services organization formed with an investment from Revelstoke Capital Partners.
  • Represented MEP Health, a Maryland-based physician emergency medicine group, in its merger with U.S. Acute Care Solutions.
  • Represented Mount Sinai Health System in its joint ventures with The Children’s Hospital of Philadelphia (CHOP) and National Jewish Health.
  • Represented North Haven Credit Partners in connection with an investment and loan to Code 3, free standing emergency room centers in Texas and Nevada.
  • Represented Northern Westchester Hospital in its strategic health system affiliation with Northwell Health.
  • Represented Richmond University Medical Center in its acquisition of St. Vincent’s Staten Island Hospital, and sale of its interest in The Heart Institute to Staten Island University Hospital.
  • Represented Sentinel Capital Partners in their investment in MB2 Dental Solutions, a dental service organization with 85 affiliated practices.
  • Represented Sephardic Nursing and Rehabilitation Center in its sale to Allure, Inc. Solera Capital in the sale of its portfolio company The Little Clinic to the retailer Kroger, Inc.
  • Represented South Nassau Communities Hospital in its acquisition of Long Beach Medical Center.
  • Represented St. Luke’s-Roosevelt Hospital Center, Inc. in the spin-off of its outpatient primary care clinics to an affiliate of William F. Ryan Community Health Center, Inc.
  • Represented Teladoc, Inc., in connection with state licensing and regulatory compliance matters.
  • Represented Town Hall Ventures in its co-investment in VillageMD.
  • Represented Virginia Eye Consultants in its sale to CEI Vision Partners.
  • Represented WellBox, Inc. in its establishment of a Medicare chronic care management (CCM)

King & Spalding’s healthcare industry practice has grown to encompass more than 400 professionals who serve the entire spectrum of healthcare providers, practitioners, investors, manufacturers, suppliers, vendors, educators, researchers, and inventors.

Our growth as a professional firm to the healthcare industry is attributable to our track record in achieving outcomes our clients value. We become partners with our clients in developing and executing complex transactions, litigation strategies, government reimbursement solutions, regulatory compliance initiatives, managed care contracting strategies, and efficiency/cost reduction measures. We understand our clients’ business operations and shape our advice and counsel to the achievement of our clients’ strategic objectives. Our clients tell us that we excel not only in efficiently delivering uncompromising quality, but also in making our clients’ problems our own.

We participate directly in the industry ourselves, serving as trusted advisors, commentators on business trends, and advocates for the advancement of healthcare policy. Over the years we have been fortunate to have some of the best and brightest talents in our field join us in this work.

King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,300 lawyers in 24 offices in the United States, Europe, the Middle East and Asia.

The firm has handled matters in over 160 countries on six continents and consistently earns recognition for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients.

Richard Zall comes recommended for his deep strength in advisory work, particularly in connection with corporate restructuring. He often counsels major healthcare providers on sales, finance issues and service agreements.”
Chambers & Partners